Bright Green Corporation (BGXX)
USD 0.04
(0.0%)
USD 0.04
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | - USD | 59.12% |
| 2022 | - USD | -1418.15% |
| 2021 | -1.73 Million USD | 13.38% |
| 2020 | -2 Million USD | -486.38% |
| 2019 | -342.31 Thousand USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -1.37 Million USD | 20.42% |
| 2024 Q1 | -1.73 Million USD | -31.37% |
| 2023 Q3 | -1.95 Million USD | 30.83% |
| 2023 FY | - USD | 59.12% |
| 2023 Q4 | -1.31 Million USD | 32.51% |
| 2023 Q1 | -2.45 Million USD | -69.09% |
| 2023 Q2 | -2.82 Million USD | -15.16% |
| 2022 Q2 | -12.68 Million USD | -2273.72% |
| 2022 Q1 | -534.54 Thousand USD | 26.96% |
| 2022 FY | - USD | -1418.15% |
| 2022 Q4 | -1.45 Million USD | 74.25% |
| 2022 Q3 | -5.63 Million USD | 55.58% |
| 2021 Q4 | -731.8 Thousand USD | -66.8% |
| 2021 FY | - USD | 13.38% |
| 2021 Q3 | -438.72 Thousand USD | -79.77% |
| 2021 Q2 | -244.04 Thousand USD | 24.72% |
| 2021 Q1 | -324.17 Thousand USD | 14.58% |
| 2020 FY | - USD | -486.38% |
| 2020 Q4 | -379.49 Thousand USD | 62.86% |
| 2020 Q3 | -1.02 Million USD | -66.9% |
| 2020 Q2 | -612.31 Thousand USD | -72.56% |
| 2020 Q1 | -354.83 Thousand USD | 0.0% |
| 2019 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| BioQuest Corp. | -33.57 USD | 100.0% |
| Clever Leaves Holdings Inc. | -16.8 Million USD | 100.0% |
| Eagle Pharmaceuticals, Inc. | 77.5 Million USD | 100.0% |
| Guardion Health Sciences, Inc. | -3.92 Million USD | 100.0% |
| GSRX Industries Inc. | - USD | NaN% |
| High Sierra Technologies, Inc. | -181.97 Thousand USD | 100.0% |
| Instadose Pharma Corp. | - USD | NaN% |